Company intelligence / Profile preview

Dianalabs

Vestec u Prahy / Prague area, Central Bohemia Region, Czech Republicdianalabs.ch ↗

Ownership: Private
Development stage: Commercial

Overview

DIANA Biotechnologies rapidly scaled during COVID‑19 to become the largest producer of PCR tests in Czechia, supplying over 40% of national demand at peak. Their PCR products were highly sensitive and enabled high-throughput testing. Post-pandemic, they reinvested profits into expanding R&D across molecular diagnostics, monoclonal antibodies, and drug discovery services[1][3].

Modalities: Small moleculeMonoclonal antibodyOligonucleotide
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Dianalabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dianalabs.

Explore the full profile